Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1980 1
1981 1
1982 1
1983 3
1984 2
1985 5
1986 6
1987 2
1988 5
1989 10
1990 3
1991 8
1992 8
1993 8
1994 14
1995 14
1996 16
1997 21
1998 24
1999 17
2000 38
2001 21
2002 25
2003 19
2004 33
2005 37
2006 28
2007 22
2008 21
2009 19
2010 24
2011 16
2012 23
2013 12
2014 9
2015 13
2016 8
2017 10
2018 8
2019 7
2020 9
2021 6
2022 6
2023 17
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

573 results

Results by year

Filters applied: . Clear all
Page 1
Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT.
Senjo H, Harada S, Kubota SI, Tanaka Y, Tateno T, Zhang Z, Okada S, Chen X, Kikuchi R, Miyashita N, Onozawa M, Goto H, Endo T, Hasegawa Y, Ohigashi H, Ara T, Hasegawa Y, Murakami M, Teshima T, Hashimoto D. Senjo H, et al. Among authors: ohigashi h. Blood. 2023 Aug 3;142(5):477-492. doi: 10.1182/blood.2023019875. Blood. 2023. PMID: 37216687
Gilteritinib enhances graft-versus-leukemia effects against FLT3-ITD mutant leukemia after allogeneic hematopoietic stem cell transplantation.
Zhang Z, Hasegawa Y, Hashimoto D, Senjo H, Kikuchi R, Chen X, Yoneda K, Sekiguchi T, Kawase T, Tsuzuki H, Ishio T, Ara T, Ohigashi H, Nakagawa M, Teshima T. Zhang Z, et al. Among authors: ohigashi h. Bone Marrow Transplant. 2022 May;57(5):775-780. doi: 10.1038/s41409-022-01619-4. Epub 2022 Feb 28. Bone Marrow Transplant. 2022. PMID: 35228711 Free article.
Neurolymphomatosis in Intravascular Large B-cell Lymphoma.
Miyajima T, Ohigashi H, Yaguchi H, Teshima T. Miyajima T, et al. Among authors: ohigashi h. Intern Med. 2023 May 1;62(9):1381-1382. doi: 10.2169/internalmedicine.0021-22. Epub 2022 Oct 5. Intern Med. 2023. PMID: 36198588 Free PMC article. No abstract available.
Hepatitis B virus reactivation with a rituximab-containing regimen.
Tsutsumi Y, Yamamoto Y, Ito S, Ohigashi H, Shiratori S, Naruse H, Teshima T. Tsutsumi Y, et al. Among authors: ohigashi h. World J Hepatol. 2015 Sep 28;7(21):2344-51. doi: 10.4254/wjh.v7.i21.2344. World J Hepatol. 2015. PMID: 26413224 Free PMC article. Review.
Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation.
Fuji S, Sugita J, Najima Y, Konishi T, Tanaka T, Ohigashi H, Eto T, Nagafuji K, Hiramoto N, Matsuoka KI, Maruyama Y, Ota S, Ishikawa J, Kawakita T, Akasaka T, Kamimura T, Hino M, Fukuda T, Atsuta Y, Yakushijin K. Fuji S, et al. Among authors: ohigashi h. Br J Haematol. 2024 Mar;204(3):959-966. doi: 10.1111/bjh.19228. Epub 2023 Nov 30. Br J Haematol. 2024. PMID: 38037468
Intestinal Lymphatic Endothelial Cells Produce R-Spondin3.
Ogasawara R, Hashimoto D, Kimura S, Hayase E, Ara T, Takahashi S, Ohigashi H, Yoshioka K, Tateno T, Yokoyama E, Ebata K, Kondo T, Sugita J, Onozawa M, Iwanaga T, Teshima T. Ogasawara R, et al. Among authors: ohigashi h. Sci Rep. 2018 Jul 16;8(1):10719. doi: 10.1038/s41598-018-29100-7. Sci Rep. 2018. PMID: 30013036 Free PMC article.
[Bing-Neel syndrome successfully treated with tirabrutinib].
Yokoyama K, Ohigashi H, Miyajima T, Miyashita N, Okada S, Hasegawa Y, Sugita J, Onozawa M, Hashimoto D, Teshima T. Yokoyama K, et al. Among authors: ohigashi h. Rinsho Ketsueki. 2022;63(8):870-875. doi: 10.11406/rinketsu.63.870. Rinsho Ketsueki. 2022. PMID: 36058857 Japanese.
Ursolic acid: an anti- and pro-inflammatory triterpenoid.
Ikeda Y, Murakami A, Ohigashi H. Ikeda Y, et al. Among authors: ohigashi h. Mol Nutr Food Res. 2008 Jan;52(1):26-42. doi: 10.1002/mnfr.200700389. Mol Nutr Food Res. 2008. PMID: 18203131 Review.
Effect of graft-versus-host disease on outcomes of HLA-haploidentical peripheral blood transplantation using post-transplant cyclophophamide.
Shimomura Y, Komukai S, Kitamura T, Sobue T, Akahoshi Y, Kanda J, Ohigashi H, Nakamae H, Hiramoto N, Nagafuji K, Tanaka T, Eto T, Ota S, Maruyama Y, Akasaka T, Matsuoka KI, Mori Y, Fukuda T, Atsuta Y, Terakura S. Shimomura Y, et al. Among authors: ohigashi h. Bone Marrow Transplant. 2024 Jan;59(1):66-75. doi: 10.1038/s41409-023-02142-w. Epub 2023 Oct 28. Bone Marrow Transplant. 2024. PMID: 37898725
Pathological Nodal and Vascular Involvement Significantly Impacts the Recurrence Risk in Different Time Frames in Patients With Resectable and Borderline Resectable Pancreatic Cancer: Long-term Conditional Recurrence-free Survival Analysis in the Setting of a Neoadjuvant Treatment Strategy.
Takahashi H, Akita H, Wada H, Miyata H, Eguchi H, Ohigashi H, Sakon M, Ishikawa O. Takahashi H, et al. Among authors: ohigashi h. Ann Surg. 2023 Dec 1;278(6):e1216-e1223. doi: 10.1097/SLA.0000000000005879. Epub 2023 Apr 14. Ann Surg. 2023. PMID: 37057622
573 results